However, a wide application is expected in the imaging of desmoplastic tumors with high FAP expression—especially in those not detectable by 18F-FDG PET, which include some types of metastatic colorectal tumors (peritoneal carcinomatosis) and hepatic, duodenal, and gastric cancer [15,16,17]. This evidence concerns the gene FAP and gastric cancer.